Regulus Therapeutics Statistics
Total Valuation
CQP has a market cap or net worth of $26.83 billion. The enterprise value is $41.54 billion.
Important Dates
The last earnings date was Thursday, August 7, 2025, before market open.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | Aug 8, 2025 |
Share Statistics
CQP has 484.05 million shares outstanding.
| Current Share Class | 484.05M |
| Shares Outstanding | 484.05M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 25.61% |
| Float | 142.04M |
Valuation Ratios
The trailing PE ratio is 13.45 and the forward PE ratio is 12.02.
| PE Ratio | 13.45 |
| Forward PE | 12.02 |
| PS Ratio | 2.69 |
| Forward PS | 2.38 |
| PB Ratio | 12.21 |
| P/TBV Ratio | 12.21 |
| P/FCF Ratio | 10.42 |
| P/OCF Ratio | 9.62 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 10.75, with an EV/FCF ratio of 16.14.
| EV / Earnings | 20.82 |
| EV / Sales | 4.17 |
| EV / EBITDA | 10.75 |
| EV / EBIT | 13.06 |
| EV / FCF | 16.14 |
Financial Position
The company has a current ratio of 0.61
| Current Ratio | 0.61 |
| Quick Ratio | 0.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.84 |
| Debt / FCF | 5.76 |
| Interest Coverage | 4.11 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 11.54% |
| Return on Invested Capital (ROIC) | 13.48% |
| Return on Capital Employed (ROCE) | 20.82% |
| Revenue Per Employee | $5.81M |
| Profits Per Employee | $1.16M |
| Employee Count | 1,714 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 40.29 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.28% in the last 52 weeks. The beta is 0.41, so CQP's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +10.28% |
| 50-Day Moving Average | 56.11 |
| 200-Day Moving Average | 57.77 |
| Relative Strength Index (RSI) | 48.17 |
| Average Volume (20 Days) | 168,070 |
Short Selling Information
The latest short interest is 644,353, so 0.13% of the outstanding shares have been sold short.
| Short Interest | 644,353 |
| Short Previous Month | 893,135 |
| Short % of Shares Out | 0.13% |
| Short % of Float | 0.45% |
| Short Ratio (days to cover) | 2.87 |
Income Statement
In the last 12 months, CQP had revenue of $9.96 billion and earned $2.00 billion in profits. Earnings per share was $4.12.
| Revenue | 9.96B |
| Gross Profit | 3.98B |
| Operating Income | 3.18B |
| Pretax Income | 2.95B |
| Net Income | 2.00B |
| EBITDA | 3.86B |
| EBIT | 3.18B |
| Earnings Per Share (EPS) | $4.12 |
Full Income StatementBalance Sheet
The company has $108.00 million in cash and $14.82 billion in debt, giving a net cash position of -$14.71 billion or -$30.40 per share.
| Cash & Cash Equivalents | 108.00M |
| Total Debt | 14.82B |
| Net Cash | -14.71B |
| Net Cash Per Share | -$30.40 |
| Equity (Book Value) | -340.00M |
| Book Value Per Share | 4.54 |
| Working Capital | -638.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $2.79 billion and capital expenditures -$216.00 million, giving a free cash flow of $2.57 billion.
| Operating Cash Flow | 2.79B |
| Capital Expenditures | -216.00M |
| Free Cash Flow | 2.57B |
| FCF Per Share | $5.32 |
Full Cash Flow StatementMargins
Gross margin is 39.92%, with operating and profit margins of 31.93% and 24.62%.
| Gross Margin | 39.92% |
| Operating Margin | 31.93% |
| Pretax Margin | 24.62% |
| Profit Margin | 24.62% |
| EBITDA Margin | 38.80% |
| EBIT Margin | 31.93% |
| FCF Margin | 25.85% |
Dividends & Yields
This stock pays an annual dividend of $3.28, which amounts to a dividend yield of 5.92%.
| Dividend Per Share | $3.28 |
| Dividend Yield | 5.92% |
| Dividend Growth (YoY) | -11.26% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 79.33% |
| Buyback Yield | n/a |
| Shareholder Yield | 6.01% |
| Earnings Yield | 7.44% |
| FCF Yield | 9.59% |
Dividend DetailsAnalyst Forecast
The average price target for CQP is $55.80, which is 2.18% higher than the current price. The consensus rating is "Strong Sell".
| Price Target | $55.80 |
| Price Target Difference | 2.18% |
| Analyst Consensus | Strong Sell |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 1.97% |
| EPS Growth Forecast (5Y) | -1.82% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |
